BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Williams EL, Stimpson ML, Lait PJP, Schewitz-Bowers LP, Jones LV, Dhanda AD, Lee RWJ, Bradbury CA. Glucocorticoid treatment in patients with newly diagnosed immune thrombocytopenia switches CD14++ CD16+ intermediate monocytes from a pro-inflammatory to an anti-inflammatory phenotype. Br J Haematol 2021;192:375-84. [PMID: 33338291 DOI: 10.1111/bjh.17205] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Jolink AC, Nelson VS, Schipperus MR, Amini SN, Vidarsson G, van der Schoot CE, Porcelijn L, de Haas M, Kapur R. Potential Diagnostic Approaches for Prediction of Therapeutic Responses in Immune Thrombocytopenia. J Clin Med 2021;10:3403. [PMID: 34362187 DOI: 10.3390/jcm10153403] [Reference Citation Analysis]
2 Gazzito Del Padre TC, Belem JMFM, de Aguiar MF, Torquato HFV, Paredes-Gamero EJ, Abdulahad WH, Brouwer E, de Souza AWS. Distribution of monocytes subpopulations in the peripheral blood from patients with Behçet's disease - Impact of disease status and colchicine use. Clin Immunol 2021;231:108854. [PMID: 34530137 DOI: 10.1016/j.clim.2021.108854] [Reference Citation Analysis]